4.7 Article

HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 217, 期 7, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20191422

关键词

-

资金

  1. European Research Council (ERC-AdG ENVISION) [786602]
  2. Novo Nordisk Foundation [NNF18OC0030274]
  3. Lundbeck Foundation [R198-2015-171, R268-2016-3927]
  4. EU [4092-00253]
  5. Ludwig Institute for Cancer Research
  6. Wellcome Trust [102894/Z/13/Z]
  7. Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy [EXC 2155, 39087428]
  8. Swedish Research Council [2018-02532]
  9. European Research Council [681712]
  10. Swedish State Support for Clinical Research [ALFGBG-720931]
  11. UK Dementia Research Institute
  12. Alzheimer's Drug Discovery Foundation
  13. Wellcome Trust [102894/Z/13/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Herpes simplex virus (HSV) is the main cause of viral encephalitis in the Western world, and the type I interferon (IFN) system is important for antiviral control in the brain. Here, we have compared Ifnb induction in mixed murine brain cell cultures by a panel of HSV1 mutants, each devoid of one mechanism to counteract the IFN-stimulating cGAS-STING pathway. We found that a mutant lacking the deubiquitinase (DUB) activity of the VP1-2 protein induced particularly strong expression of Ifnb and IFN-stimulated genes. HSV1 Delta DUB also induced elevated IFN expression in murine and human microglia and exhibited reduced viral replication in the brain. This was associated with increased ubiquitination of STING and elevated phosphorylation of STING, TBK1, and IRF3. VP1-2 associated directly with STING, leading to its deubiquitination. Recruitment of VP1-2 to STING was dependent on K150 of STING, which was ubiquitinated by TRIM32. Thus, the DUB activity of HSV1 VP1-2 is a major viral immune-evasion mechanism in the brain.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection

Evangelos Andreakos, Laurent Abel, Donald C. Vinh, Elzbieta Kaja, Beth A. Drolet, Qian Zhang, Cliona O'Farrelly, Giuseppe Novelli, Carlos Rodriguez-Gallego, Filomeen Haerynck, Carolina Prando, Aurora Pujol, Helen C. Su, Jean-Laurent Casanova, Andras N. Spaan, Paul Bastard, Catherine M. Biggs, Benedetta Bigio, Bertrand Boisson, Alexandre Bolze, Anastasiia Bondarenko, Petter Brodin, Samya Chakravorty, John Christodoulou, Aurelie Cobat, Antonio Condino-Neto, Stefan N. Constantinescu, Hagit Baris Feldman, Jacques Fellay, Rabih Halwani, Emmanuelle Jouanguy, Yu-Lung Lau, Isabelle Meyts, Trine H. Mogensen, Satoshi Okada, Keisuke Okamoto, Tayfun Ozcelik, Qiang Pan-Hammarstrom, Anna M. Planas, Anne Puel, Lluis Quintana-Murci, Laurent Renia, Igor Resnick, Anna Sediva, Anna Shcherbina, Ondrej Slaby, Ivan Tancevski, Stuart E. Turvey, K. M. Furkan Uddin, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Shen-Ying Zhang

Summary: SARS-CoV-2 infections can vary greatly between individuals, with some being asymptomatic while others experience life-threatening disease. While 20% of critical COVID-19 cases are due to inborn errors or autoantibodies, the genetic and immunological factors for resistance to infection itself remain unknown. Studies have shown that autosomal recessive deficiencies in certain genes or enzymes can confer resistance to diseases, suggesting a potential strategy for identifying individuals naturally resistant to SARS-CoV-2 infection.

NATURE IMMUNOLOGY (2022)

Review Immunology

Innate immunological pathways in COVID-19 pathogenesis

Soren R. Paludan, Trine H. Mogensen

Summary: COVID-19 is a disease characterized by significant dysregulation of the innate immune system. The activation of specific pattern recognition receptors by SARS-CoV-2 and host-derived molecules leads to protective interferon responses and pathological cytokine responses. These pathways are modulated by virus-host interactions and host stress-sensing pathways.

SCIENCE IMMUNOLOGY (2022)

Article Immunology

Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic

Christopher J. A. Duncan, Morten K. Skouboe, Sophie Howarth, Anne K. Hollensen, Rui Chen, Malene L. Borresen, Benjamin J. Thompson, Jarmila Stremenova Spegarova, Catherine F. Hatton, Frederik F. Staeger, Mette K. Andersen, John Whittaker, Soren R. Paludan, Sofie E. Jorgensen, Martin K. Thomsen, Jacob G. Mikkelsen, Carsten Heilmann, Daniela Buhas, Nina F. Obro, Jakob T. Bay, Hanne Marquart, M. Teresa de la Morena, Joseph A. Klejka, Matthew Hirschfeld, Line Borgwardt, Isabel Forss, Tania Masmas, Anja Poulsen, Francisco Noya, Guy Rouleau, Torben Hansen, Sirui Zhou, Anders Albrechtsen, Reza Alizadehfar, Eric J. Allenspach, Sophie Hambleton, Trine H. Mogensen

Summary: This study investigated five children from Greenland, Canada, and Alaska who carried a homozygous IFNAR2 gene variant, resulting in increased vulnerability to viral infections. This finding highlights the essential role of Type I interferons in viral immunity and suggests the need for further population screening studies.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Biology

The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses

Manutea C. Serrero, Virginie Girault, Sebastian Weigang, Todd M. Greco, Ana Ramos-Nascimento, Fenja Anderson, Antonio Piras, Ana Hickford Martinez, Jonny Hertzog, Anne Binz, Anja Pohlmann, Ute Prank, Jan Rehwinkel, Rudolf Bauerfeind, Ileana M. Cristea, Andreas Pichlmair, Georg Kochs, Beate Sodeik, Adam P. Geballe

Summary: This study identifies an interferon-inducible protein, MxB, that can sense herpesviral capsids and disassemble them, thereby restricting viral nuclear targeting and progeny capsid assembly, leading to enhanced innate immune responses.
Article Clinical Neurology

Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology

Jane Agergaard, Benjamin Yamin Ali Khan, Thomas Engell-Sorensen, Berit Schiottz-Christensen, Lars ostergaard, Eva K. Hejbol, Henrik D. Schroder, Henning Andersen, Jakob Udby Blicher, Thomas Holm Pedersen, Thomas Harbo, Hatice Tankisi, M. U. L. T. I. C. O. V. Consortium MULTICOV Consortium

Summary: This study examined 84 patients with long COVID using qEMG and sfEMG, and performed muscle biopsies in a subset of patients. The results showed that the mean MUP duration was decreased in >= 1 muscles in 52% of the patients, and the mean jitter was increased in 17% of the patients in the tibialis anterior and 25% in the extensor digitorum communis. Muscle biopsies revealed damage of terminal nerves and motor endplate with abundant basal lamina material. These findings suggest a muscle pathophysiology behind fatigue in long COVID.

CLINICAL NEUROPHYSIOLOGY (2023)

Article Infectious Diseases

Successful use of interferon alfa-2a for persistent parvovirus B19 infection

Trine H. Mogensen, Morten Kelder Skouboe, Ingolf Molle

Summary: Human infection with parvovirus B19 can lead to various clinical manifestations, and treatment can be challenging. This case report presents a 43-year-old man with persistent parvovirus B19 infection and anaemia. The patient showed resistance to standard treatments but responded well to pegylated interferon alfa-2a. This highlights the potential of interferon alfa-2a as a treatment option for persistent parvovirus B19 infection.

LANCET INFECTIOUS DISEASES (2023)

Article Genetics & Heredity

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, Adrian Gervais, Paul Bastard, Takaki Asano, Lucy Bizien, Federica Barzaghi, Hassan Abolhassani, Ahmad Abou Tayoun, Alessandro Aiuti, Ilad Alavi Darazam, Luis M. Allende, Rebeca Alonso-Arias, Andres Augusto Arias, Gokhan Aytekin, Peter Bergman, Simone Bondesan, Yenan T. Bryceson, Ingrid G. Bustos, Oscar Cabrera-Marante, Sheila Carcel, Paola Carrera, Giorgio Casari, Khalil Chaibi, Roger Colobran, Antonio Condino-Neto, Laura E. Covill, Ottavia M. Delmonte, Loubna El Zein, Carlos Flores, Peter K. Gregersen, Marta Gut, Filomeen Haerynck, Rabih Halwani, Selda Hancerli, Lennart Hammarstroem, Nevin Hatipoglu, Adem Karbuz, Sevgi Keles, Christele Kyheng, Rafael Leon-Lopez, Jose Luis Franco, Davood Mansouri, Javier Martinez-Picado, Ozge Metin Akcan, Isabelle Migeotte, Pierre-Emmanuel Morange, Guillaume Morelle, Andrea Martin-Nalda, Giuseppe Novelli, Antonio Novelli, Tayfun Ozcelik, Figen Palabiyik, Qiang Pan-Hammarstroem, Rebeca Perez de Diego, Laura Planas-Serra, Daniel E. Pleguezuelo, Carolina Prando, Aurora Pujol, Luis Felipe Reyes, Jacques G. Riviere, Carlos Rodriguez-Gallego, Julian Rojas, Patrizia Rovere-Querini, Agatha Schlueter, Mohammad Shahrooei, Ali Sobh, Pere Soler-Palacin, Yacine Tandjaoui-Lambiotte, Imran Tipu, Cristina Tresoldi, Jesus Troya, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Saleh Zaid Al-Muhsen, Mohammed Faraj Alosaimi, Fahad M. Alsohime, Hagit Baris-Feldman, Manish J. Butte, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Jacques Fellay, James R. Heath, Yu-Lung Lau, Richard P. Lifton, Tom Maniatis, Trine H. Mogensen, Horst von Bernuth, Alban Lermine, Michel Vidaud, Anne Boland, Jean-Francois Deleuze, Robert Nussbaum, Amanda Kahn-Kirby, France Mentre, Sarah Tubiana, Guy Gorochov, Florence Tubach, Pierre Hausfater, C. O. V. I. D. Human Genetic Effort, Isabelle Meyts, Shen-Ying Zhang, Anne Puel, Luigi D. Notarangelo, Stephanie Boisson-Dupuis, Helen C. Su, Bertrand Boisson, Emmanuelle Jouanguy, Jean-Laurent Casanova, Qian Zhang, Laurent Abel, Aurelie Cobat

Summary: Through a genome-wide rare variant burden association analysis, it was found that there is an association between at-risk variants in the TLR7 gene and rare loss-of-function variants in TLR3-dependent type I interferon immunity genes. These findings suggest that rare variants in TLR3- and TLR7-dependent type I interferon immunity genes may underlie life-threatening COVID-19 in patients under 60 years old.

GENOME MEDICINE (2023)

Review Microbiology

Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System

Morten Kelder Skouboe, Marvin Werner, Trine H. Mogensen

Summary: Herpesvirus infections can cause severe clinical manifestations in the central nervous system, but the understanding of the underlying host factors is incomplete. Defects in innate immune pathways and interferon production have been found to predispose individuals to herpes simplex encephalitis. Recent evidence suggests that IFN-independent intrinsic mechanisms play a crucial role in restricting herpesvirus replication and protecting against CNS infection. This review discusses clinical manifestations, host-pathogen interactions, and inborn errors of immunity that increase susceptibility to HSV CNS infection, highlighting the unanswered questions and future research directions in the pathogenesis of these diseases.

PATHOGENS (2023)

Article Biology

STING is redundant for host defense and pathology of COVID-19-like disease in mice

Giorgia Marino, Baocun Zhang, Alexander Schmitz, Hanna V. F. Schwensen, Line S. Reinert, Soren R. Paludan

Summary: Critical COVID-19 is characterized by a lack of early antiviral defense and excessive lung inflammation. The aberrant activation of immune cells has been suggested to contribute to the pathology, with the DNA-sensing cGAS-STING pathway being implicated. However, this study using a mouse model found no evidence supporting a role for STING in COVID-19 pathology, as STING deficiency did not alter disease development or immune response.

LIFE SCIENCE ALLIANCE (2023)

Article Oncology

STING activation counters glioblastoma by vascular alteration and immune surveillance

Justin V. Joseph, Mathilde S. Blaavand, Huiqiang Cai, Fabienne Vernejoul, Rasmus W. Knopper, Thomas B. Lindhardt, Kristian A. Skipper, Esben Axelgaard, Line Reinert, Jacob G. Mikkelsen, Per Borghammer, Soren E. Degn, Eric Perouzel, Henrik Hager, Brian Hansen, Joanna M. Kalucka, Mikkel Vendelbo, Soren R. Paludan, Martin K. Thomsen

Summary: This study focused on glioblastoma and investigated the activation of the innate immune system through long-term STING activation as a potential treatment approach. The results showed that this approach reduced tumor progression and prolonged survival. Additionally, prolonged STING activation led to alterations in tumor vasculature and activation of VEGFR. Combination treatment with anti-PD1 did not provide any additional benefits, suggesting that STING activation alone is sufficient to hinder tumor development.

CANCER LETTERS (2023)

Article Biochemistry & Molecular Biology

ER stress induces caspase-2-tBID-GSDMEdependent cell death in neurons lytically infected with herpes simplex virus type 2

Fanghui Ren, Ryo Narita, Ahmad S. Rashidi, Stefanie Fruhwurth, Zongliang Gao, Rasmus O. Bak, Martin K. Thomsen, Georges M. G. M. Verjans, Line S. Reinert, Soren R. Paludan

Summary: Neurotropic viruses such as herpes simplex virus (HSV) can infect neurons and cause severe diseases. HSV-induced neuronal cell death is mediated by gasdermin E (GSDME) and involves endoplasmic reticulum stress, caspase activation, and mitochondria-dependent apoptosis. The necrotic neurons release alarmins, triggering inflammatory responses in microglia.

EMBO JOURNAL (2023)

Article Virology

Examination of autoantibodies to type I interferon in patients suffering from long COVID

Kristoffer Skaalum Hansen, Sofie Eg Jorgensen, Morten Kelder Skouboe, Jane Agergaard, Berit Schiottz-Christensen, Line Khalidan Vibholm, Martin Tolstrup, Lars Ostergaard, Steffen Leth, Trine H. Mogensen

Summary: Long COVID is an emerging global health concern, and its underlying mechanism and pathophysiology are still unclear. This study found that autoantibodies against type 1 interferons in patients with Long COVID do not contribute to the symptoms.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Multidisciplinary Sciences

TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain

Stefanie Fruhwurth, Line S. Reinert, Carl Oberg, Marcelina Sakr, Marcus Henricsson, Henrik Zetterberg, Soren R. Paludan

Summary: Immunological control of viral infections in the brain, especially through the TREM2 pathway, is crucial for protection against herpes simplex virus type 1 (HSV1) infection and maintenance of brain integrity. The down-regulation of TREM2 expression in HSV1-infected microglia leads to impaired antiviral response and decreased ability to phagocytose infected neurons. This study highlights the importance of TREM2 in the immune defense against viral infections and raises questions about its role in neurological pathologies.

SCIENCE ADVANCES (2023)

Article Medicine, Research & Experimental

An IKBKE variant conferring functional cGAS/STING pathway deficiency and susceptibility to recurrent HSV-2 meningitis

Azadeh Reyahi, Marie Studahl, Morten K. Skouboe, Stefanie Fruhwurth, Ryo Narita, Fanghui Ren, Moa Bjerhem Viklund, Marie B. Iversen, Mette Christiansen, Alexandra Svensson, Trine H. Mogensen, Kristina Eriksson, Soren R. Paludan

Summary: This study reveals the importance of the IKBKE gene and the cGAS/STING pathway in protecting against recurrent HSV-2 meningitis. A monoallelic variant in the IKBKE gene was identified in a patient with multiple episodes of HSV-2 meningitis, leading to impaired induction of IFN genes and decreased antiviral activity. The patient allele encoded a truncated IKK epsilon protein with loss of kinase activity and dominant-negative activity. Reintroducing wild-type IKBKE into patient cells restored IFN induction and antiviral activity. These findings highlight the nonredundant role of the cGAS/STING pathway in human antiviral immunity.

JCI INSIGHT (2023)

暂无数据